Naoki Shinno

Toyonaka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 77 publications

A Case of MSI‒High Advanced or Recurrent Gastric Cancer Showed Complete Response to Pembrolizumab as Third‒Line Treatment

A Case of MSI‒High Advanced or Recurrent Gastric Cancer Showed Complete Response to Pembrolizumab as Third‒Line Treatment

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: February 26, 2026

Exercise-nutrition prehabilitation attenuates lean body mass loss before gastrectomy: a randomized controlled trial.

Exercise-nutrition prehabilitation attenuates lean body mass loss before gastrectomy: a randomized controlled trial.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: February 18, 2026

Treatment Outcomes for Six Cases of Gastric Cancer with Brain Metastases

Treatment Outcomes for Six Cases of Gastric Cancer with Brain Metastases

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: January 17, 2026

Ascending Colon Cancer with Duodenal Invasion Treated with Preoperative Chemotherapy and Partial Duodenectomy

Ascending Colon Cancer with Duodenal Invasion Treated with Preoperative Chemotherapy and Partial Duodenectomy

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: January 17, 2026

Neoadjuvant docetaxel, oxaliplatin, and S-1 therapy for patients with large type 3 or type 4 gastric cancer: final outcomes of a multicenter, phase II study (OGSG 1902).

Neoadjuvant docetaxel, oxaliplatin, and S-1 therapy for patients with large type 3 or type 4 gastric cancer: final outcomes of a multicenter, phase II study (OGSG 1902).

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: October 13, 2025

Efficacy and safety of anamorelin for cancer cachexia in patients with unresectable or recurrent gastric cancer: a multicentre, open-label, randomised controlled trial.

Efficacy and safety of anamorelin for cancer cachexia in patients with unresectable or recurrent gastric cancer: a multicentre, open-label, randomised controlled trial.

Journal: EClinicalMedicine

Published: June 25, 2025

Endoscopic Full-thickness Resection for Gastric Submucosal Tumor: A Technical Analysis Study (With Video).

Endoscopic Full-thickness Resection for Gastric Submucosal Tumor: A Technical Analysis Study (With Video).

Journal: DEN open

Published: June 17, 2025

Evaluation of usefulness of manual reduction in the management of adult acute irreducible abdominal wall hernia: a study from a community-based teaching hospital.

Evaluation of usefulness of manual reduction in the management of adult acute irreducible abdominal wall hernia: a study from a community-based teaching hospital.

Journal: Hernia : the journal of hernias and abdominal wall surgery

Published: May 19, 2025

A Case of Small Bowel Obstruction Caused by an Intraoperatively Recognized Low-Grade Appendiceal Mucinous Neoplasm

A Case of Small Bowel Obstruction Caused by an Intraoperatively Recognized Low-Grade Appendiceal Mucinous Neoplasm

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: February 14, 2025

Three Cases of Sigmoid Colon Cancer with Bladder Invasion That Were Treated with Neoadjuvant Chemotherapy, Allowing Radical Resection and Bladder Preservation

Three Cases of Sigmoid Colon Cancer with Bladder Invasion That Were Treated with Neoadjuvant Chemotherapy, Allowing Radical Resection and Bladder Preservation

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: February 14, 2025

Postoperative Prognostic Nutritional Index as a Useful Prognostic Factor in Patients With Gastric Cancer.

Postoperative Prognostic Nutritional Index as a Useful Prognostic Factor in Patients With Gastric Cancer.

Journal: Annals of gastroenterological surgery

Published: February 13, 2025

Neoadjuvant docetaxel, oxaliplatin, and S-1 therapy for patients with large type 3 or type 4 gastric cancer: short-term outcomes of a multicenter, phase II study (OGSG1902).

Neoadjuvant docetaxel, oxaliplatin, and S-1 therapy for patients with large type 3 or type 4 gastric cancer: short-term outcomes of a multicenter, phase II study (OGSG1902).

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: January 26, 2025

Showing 1-12 of 77

Last Updated: 09/26/2026